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It is clear from our commentary (Goldman
and Silbergeld 2013), that we disagree with
Lutter et al. (2013) about whether the public disclosure of all raw data used by the
U.S. Environmental Protection Agency (EPA)
for making regulatory decisions for chemicals
is necessary to ensure the scientific basis for
such decisions, and about the extent to which
preemptive disclosure (prior to any request)
is practical. However, the most important
disagreement between us is the basis asserted
by Lutter et al. in their commentary for this
change in policy. Lutter et al. argued that it
is necessary for the U.S. EPA—and anyone
else who desires to do so—to reanalyze all
data used in their assessments in order to
“replicate” the findings and conclusions of
the original investigators.
Environmental Health Perspectives

Lutter et al. (2013) repeatedly used the
terms “replicability” and “replication” as
synonymous with an “independent analysis” of raw data from an existing study.
Replication in science is quite different; it
involves performance of an independent study
with the same hypothesis and then testing
the extent to which this independent study
reaches the same conclusions. Recalculation
of study statistics or other reanalysis of an
existing study data set is not a replication.
Designing and conducting a replication study
does not require access to raw data from the
original study; this would abrogate the concept of independence. Moreover, an independent study will by definition utilize different
sets of animal models or human populations,
and as a consequence may employ different
statistical techniques.
Their second argument is that disclosure
of raw data will assist in identifying sources
of scientific bias. We consider this unlikely
because the most important sources of bias
are usually related to problems in study design
or limitations of the data collected. This is not
identifiable through data recalculation; however, this type of bias can usually be identified
in the text of the original study publication.
Lutter et al. (2013) noted (correctly) that
applicants to the U.S. EPA for pesticide regis
trations must provide raw data from regulatory testing as part of the package submitted
to the U.S. EPA. This is a very special case, in
that these studies are neither peer reviewed nor
accessible to the public because of the protection sought by industry and extended by law
for confidential business information (CBI).
The assumption of bias related to these studies is not unreasonable, given that they are
conducted by or on behalf of commercial entities seeking to obtain pesticide registration.
These studies are rarely published in the scien
tific literature or in any way subject to independent peer review other than review by the
U.S. EPA. Many scientists and public policy
practitioners consider the CBI cloak as a major
impediment to transparency and confidence.
Industry could demonstrate their commitment
to transparency by declining this protection,
thereby increasing the confidence of all.
Finally, Lutter et al. (2013) attempted to
support their proposal by claiming that journals [Nature and the Proceedings of the National
Academy of Sciences of the United States
(PNAS)] and an expert body (the Bipartisan
Policy Center) agree with them. However,
these bodies have neither supported the concept of requiring that all raw data be reported
to the the U.S. EPA nor that the U.S. EPA
carry out its own independent recalculation.
Rather, Nature and PNAS require authors to
agree to make data sets (as well as materials
and protocols) available to editors, and to others, upon request (Nature Publishing Group
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2012; PNAS 2012). One of us (L.R.G.) was
a member of the Science for Policy Project; its
final report (Bipartisan Policy Center 2009)
also recommended this practice. Many journals require data, such as DNA and protein
sequences, macromolecular structures, micro
array data, and crystallographic data, to be
made available on publicly accessible databases, but most of these are not “raw data” in
the sense that Lutter et al. proposed. Nature
also recommends that authors submit clinical
trials data to external clinical trials databases
(Nature Publishing Group 2012).
In summary, we disagree with the argu
ment that raw data from every study used by
the U.S. EPA to support a regulatory assess
ment should be made available to the agency
and to the public. This proposal does not
serve the purpose of “replication” or identi
fication of bias, as asserted by Lutter et al.
(2013). In practice, it may generate obstacles
to good science and discourage researchers
from studying issues of importance in
environmental health. This proposal would
also limit the U.S. EPA from using the results
of research published in the peer-reviewed
scientific literature by placing studies offlimits if the authors did not submit raw
data sets to the the U.S. EPA.
Finally, there is no obvious need for these
changes. When the U.S. EPA has determined
a need to reanalyze data, the current regulatory practice has not impeded such activities.
Past history indicates that difficult cases are
rare and do not warrant an intrusive and
burdensome new requirement for the automatic submission of data from all studies.
L.R.G. lists her affiliation for the purpose of
identification only.
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We appreciate the attention paid by Goldman
and Silbergeld (2013) to the issue of data disclosure and agree that there has been “increased
demand for transparency and disclosure of the
data used by the U.S. EPA [Environmental
Protection Agency] to make evaluations that
support regulatory decisions.”
In their letter, Goldman and Silbergeld
contend primarily that “replication” in science
means to independently repeat a prior study
to see if the same results can be obtained.
They suggest that public availability of the
prior study’s data is unnecessary because a subsequent study will generate its own data. In
2011, a special section of Science (Vol. 334,
No. 6060) addressed replicability and reproducibility and made two general points. First,
“replication,” as defined by Goldman and
Silbergeld, while perhaps the cornerstone of
the scientific method, can be difficult in many
settings because of the uniqueness of the precise conditions surrounding field observations,
the expense and time required to collect data
(e.g., for longitudinal studies), and ethical constraints (e.g., Jasny et al. 2011). Second, in
those cases where conduct of a second experiment may be impossible or infeasible, review
and reanalysis of the first study’s data is still
a meaningful step along the “reproducibility
spectrum,” assists in understanding the differences between competing analyses, and “may
be sufficient to verify the quality of the scientific claims” (Peng 2011; see also Ioannides
and Khoury 2011; Santer et al. 2011).
Other empirical work also supports the
view that data availability promotes reproducibility. In empirical economics, a discipline that uses large-scale statistical models
broadly similar to those of epidemiologists, a
famous study of replication of peer-reviewed
research suggested that inadvertent errors may
be “commonplace rather than rare occurrences” (Dewald et al. 1986). The American
Economic Review (AER 2013) subsequently
adopted a policy “to publish papers only if
the data used in the analysis are clearly and
precisely documented and are readily available
to any researcher for purposes of replication.”
Further, the AER conducted a recent evaluation of its policy and reported that about
80% of 39 sampled papers met the spirit of
the data availability policy (Glandon 2010).
Importantly, independent efforts at replication
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of 9 selected papers found no serious errors
(almost exact replication for 5 studies and
“several small discrepancies … immaterial to
the conclusions” for another 4.) This result
represents a marked improvement relative to
the results of the original 1986 study of replication. The difference is presumably attributable, at least in part, to the difference in care
and quality of work associated with the AER’s
current policy of data availability. Although
analytic methods underlying papers published
in the AER are different from those used in
chemical evaluation, the experience of the
AER suggests that there is merit in promoting
data availability for the purpose of improving
the reliability of the results of published, peerreviewed scientific papers, at least in disciplines
that use complex statistical models.
Finally, we, like Goldman and Silbergeld,
“disagree with the argument that raw data
from every study used by the U.S. EPA to
support a regulatory assessment should be
made available to the agency and to the public.” Unlike Goldman and Silbergeld, we
recommend that the U.S. EPA, when it uses
results of a published study in a regulatory
assessment, ask the authors for underlying
data (Lutter et al. 2013). If the U.S. EPA does
not receive such data, it should explain how it
used the study results in light of the fact that
data sufficient to assess reproducibility was
not forthcoming. We believe our approach
would facilitate and not obstruct good science
and that it would not discourage researchers
from studying issues of importance in environ
mental health. Moreover, it would not, as
Goldman and Silbergeld state,
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limit the U.S. EPA from using the results of
research published in the peer-reviewed scientific literature by placing studies off-limits if
the authors did not submit raw data sets to the
U.S. EPA.

R.L., an independent consultant, consults for
CropLife America (CLA) and received financial
support from the CLA to moderate a forum
and serve as principal author of this letter. C.B.
consults for Dow AgroSciences LLC, an R&Dbased agrochemical producer, registrant, and
marketer. C.J.B. received CLA funding to review
and analyze scientific literature on data quality.
J.W.C. has previously received funding from the
American Chemistry Council to author work
on the quality of scientific research evaluating
chemicals. D.E. consults for a variety of pesticide
manufacturers and for the CLA. A.F. has consulted with nonprofit organizations funded by
the CLA about pesticide issues.

Randall Lutter
Independent Consultant
Bethesda, Maryland
E-mail: rwlutter@gmail.com
Craig Barrow
Craig Barrow Consulting
Gibsonia, Pennsylvania
volume 121 | number 4 | April 2013 •

Environmental Health Perspectives

